Showing 2461-2470 of 4487 results for "".
Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
https://practicaldermatology.com/programs/cme/innovations-in-oncology-learning-center-from-guidelines-to-practice-melanoma/33212/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.Can Technology Help Dermatology Rediscover Its Roots?
https://practicaldermatology.com/topics/practice-management/can-technology-help-dermatology-rediscover-its-roots/20314/If you think of health information technology only as electronic medical records, you may be dismissing a range of valuable tools.Therapeutic Advances in the Topical Management of Acne
https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/When Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://practicaldermatology.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Considering Going Direct Pay?
https://practicaldermatology.com/topics/practice-management/considering-going-direct-pay/23552/A dermatologist shares thoughts on what “direct care” really means.At-home Medical Aesthetic Devices: What Your Patients Should Be Aware Of
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/at-home-medical-aesthetic-devices-what-your-patients-should-be-aware-of/23149/Despite some reputable standouts, most consumer-grade medical aesthetic devices are manufactured overseas and sold online and tend to be of somewhat suspect quality.The Showdown: Smartphone vs. DSLR Cameras
https://practicaldermatology.com/topics/practice-management/the-showdown-smartphone-vs-dslr-cameras/23031/Consistently capturing great photos can have a huge impact on your practice. Here’s what to consider.